Evidence map›Paper›PMID 30665287›Full record

ArticleThe Korean journal of internal medicine2020

Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation.

Hyun Jeong Kim, Sang Yeol Kim, Suk Pyo Shin, Young Joo Yang, Chang Seok Bang, Gwang Ho Baik, Dong Joon Kim, Young Lim Ham, Eui Yul Choi, Ki Tae Suk

Open access · goldAbstract read
In one paragraph

Article in The Korean journal of internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Protective Effects ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Yao medicineFrontiers in pharmacology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hyun Jeong KimBoditech Central Research Institute, Chuncheon, Korea.
Sang Yeol KimDepartment of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
Suk Pyo ShinDepartment of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
Young Joo YangDepartment of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
Chang Seok BangDepartment of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
Gwang Ho BaikDepartment of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
Dong Joon KimDepartment of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
Young Lim HamDepartment of Emergency Medical Technology, Daewon University College, Jecheon, Korea.
Eui Yul ChoiBoditech Central Research Institute, Chuncheon, Korea.
Ki Tae SukDepartment of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
Hallym University · KRDaewon University College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsEnzymatic analysis of aspartate/alanine aminotransferase (AST/ALT) does not exactly represent the progression of liver fibrosis or inflammation. Immunoassay for AST (cytoplasmic [c] AST/mitochondrial [m] AST) and ALT (ALT1/ALT2) has been suggested as one alternatives for enzymatic analysis. The objective of this study was to evaluate the efficacy of immunoassay in predicting liver fibrosis and inflammation.

methodsA total of 219 patients with chronic hepatitis B (CHB) who underwent hepatic venous pressure gradient (HVPG) and liver biopsy before antiviral therapy were recruited. Serum samples were prepared from blood during HVPG. Results of biochemical parameters including enzymatic AST/ALT and immunological assays of cAST, mAST, ALT1, and ALT2 through sandwich enzyme-linked immunosorbent assay (ELISA) immunoassay with fluorescence labeled monoclonal antibodies were compared with the results of METAVIR stage of live fibrosis and the Knodell grade of inflammation.

resultsMETAVIR fibrosis stages were as follows: F0, six (3%); F1, 52 (24%); F2, 88 (40%); F3, 45 (20%); and F4, 28 patients (13%). Mean levels of AST and ALT were 121 ± 157 and 210 ± 279 IU/L, respectively. Mean HVPG score of all patients was 4.7 ± 2.5 mmHg. According to the stage of liver fibrosis, HVPG score (p < 0.001, r = 0.439) and ALT1 level (p < 0.001, r = 0.283) were significantly increased in all samples from patients with CHB. ALT (p < 0.001, r = 0.310), ALT1 (p < 0.001, r = 0.369), and AST (p < 0.001, r = 0.374) levels were positively correlated with Knodell grade of inflammation.

conclusionALT1 measurement by utilizing sandwich ELISA immunoassay can be useful method for predicting inf lammation grade and fibrosis stage in patients with CHB.

Indexed as

Aspartic AcidHepatitis B, ChronicAlanineAlanine TransaminaseAspartate AminotransferasesBiomarkersBiopsyHumansInflammationLiverLiver CirrhosisAlanineAlanine TransaminaseAspartate AminotransferasesAspartic AcidBiomarkersAlanine aminotransferaseAspartate transferaseEnzyme-linked immunosorbent assayHepatitis B, chronic

Identifiers

PMID30665287
PMCPMC7060995
OpenAlexW2911863255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.